Short Course ADT for High Risk Low/Intermediate Risk ARTERA Prostate Cancer

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
For this study, high risk prostate cancer patients with lower risk ARTERA scores will be treated with 6 months of Androgen Deprivation Therapy (ADT) in conjunction with dose escalated radiotherapy to the prostate and nodes. Specifically, patients enrolled in this study will undergo one of several dose-escalated forms of radiotherapy which would include SBRT with or without a brachytherapy boost.
Epistemonikos ID: c52dfac0eabb67079844ce5263c1020e35ff84c6
First added on: Sep 03, 2026